When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PRVB - Provention Bio pauses enrollment in PRV-031 study due to COVID-19
Provention Bio Inc.
Citing the need for caution during the COVID-19 outbreak, Provention Bio (NASDAQ:PRVB) has suspended recruitment in its Phase 3 PROTECT study evaluating teplizumab (PRV-031) in newly diagnosed type 1 diabetics.
More news on: Provention Bio, Inc., Healthcare stocks news,